圣达生物：预计2025年年度净利润为5000万元~6500万元，同比增长69.93%~120.9%

Group 1 - The company expects to achieve a net profit attributable to shareholders of the parent company between 50 million to 65 million yuan for the year 2025, representing an increase of 20.5755 million to 35.5755 million yuan compared to the same period last year, which translates to a year-on-year growth of 69.93% to 120.9% [1] - The main reasons for the performance change include the company's continuous promotion of refined management and technological upgrades, which further optimized operational efficiency and cost structure [1] - The company has deepened its differentiated competitive strategy and increased market expansion efforts, seizing market opportunities to enhance overall profitability [1]